☆ 4.4 Article

Elucidation of benzene sulfonamide derivative binding at a novel interprotomer pocket of wild type and mutants of coxsackievirus B3 viral capsid using molecular dynamics simulations and density functional theory

BIOPHYSICAL CHEMISTRY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction

Phujinn Honorio et al.

Summary: This study investigated the key binding interactions of hybrid donepezils for the treatment of Alzheimer's disease (AD) using molecular docking, molecular dynamics simulations, and quantum chemical calculations. The results revealed the important interactions between the hybrid donepezils and key residues in the binding pocket of acetylcholinesterase (AChE). The modification of the scaffolds and HOMO-LUMO predictions provided insights into the electron transfer and adaptation in the binding pocket. The bioavailability, drug-likeness, and pharmacokinetics predictions confirmed the suitability of the hybrid donepezils for AD drug development.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

Add to Collection

Article Virology

Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response

Qian Dai et al.

Summary: The study revealed the beneficial effect of berberine on CVB3-induced myocarditis in mice, suggesting its potential as a therapeutic strategy against CVB3-induced viral myocarditis.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Coxsackievirus B3 Infection Early in Pregnancy Induces Congenital Heart Defects Through Suppression of Fetal Cardiomyocyte Proliferation

Vipul Sharma et al.

Summary: Prenatal infection with CVB3 can induce congenital heart defects in fetuses, with a dose-response relationship observed between viral titers and defect severity. Following exposure to CVB3, a significant decrease in cardiomyocyte proliferation was identified as the main cause for alterations in cardiac architecture and trabeculation.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Article Biology

Identification of a conserved virion-stabilizing network inside the interprotomer pocket of enteroviruses

Justin W. Flatt et al.

Summary: Enteroviruses present a persistent and widespread threat to human physical health, with no specific treatments currently available. Small molecule capsid binders have the potential to be developed as antivirals to prevent virus attachment and entry into host cells. Structures of coxsackieviruses B3 and B4 bound to different capsid binders have been reported using single-particle cryo-EM, revealing detailed interactions and conserved virion-stabilizing networks at the interprotomer site.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations

Phujinn Honorio et al.

Summary: The research discovered that protoberberine alkaloids isolated from natural resources are potent inhibitors of acetylcholinesterase (AChE) and have the potential to reduce symptoms of Alzheimer's disease. The key interactions of palmatine and berberine with AChE were identified as 7C-7C interactions with specific amino acids and H-bond interactions. In contrast, cyclanoline showed a different binding mode and preference for a deeper site within AChE.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Add to Collection

Article Virology

In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3

Yafeng Wang et al.

Summary: The novel fluoronucleoside analogue NCC demonstrated significant antiviral activities against CVB3, inhibiting virus replication, alleviating myocardial injury, and suppressing apoptosis in HeLa cells and infected mice. It shows potential as a therapeutic agent for viral myocarditis.

ACTA VIROLOGICA (2021)

Add to Collection

Article Chemistry, Medicinal

Synthesis and anti-CVB3 activity of 4-amino acid derivative substituted pyrimidine nucleoside analogues

Le Tao et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives

Yanhong Wei et al.

MOLECULES (2020)

Add to Collection

Article Infectious Diseases

High proportion of coxsackievirus B3 genotype A in hand, foot and mouth disease in Zhenjiang, China, 2011-2016

Xuemin Fu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Biochemistry & Molecular Biology

A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses

Rana Abdelnabi et al.

PLOS BIOLOGY (2019)

Add to Collection

Review Chemistry, Medicinal

Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses

Anna Egorova et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

ICTV Virus Taxonomy Profile: Picornaviridae

R. Zell et al.

JOURNAL OF GENERAL VIROLOGY (2017)

Add to Collection

Article Virology

MOPS and coxsackievirus B3 stability

Steven D. Carson et al.

VIROLOGY (2017)

Add to Collection

Article Public, Environmental & Occupational Health

Metagenomics Study of Viral Pathogens in Undiagnosed Respiratory Specimens and Identification of Human Enteroviruses at a Thailand Hospital

Yanfei Zhou et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)

Add to Collection

Article Pharmacology & Pharmacy

Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses

Hyunju Kang et al.

ANTIVIRAL RESEARCH (2015)

Add to Collection

Article Chemistry, Medicinal

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses

Vadim A. Makarov et al.

CHEMMEDCHEM (2015)

Add to Collection

Review Microbiology

Coxsackievirus B3 replication and pathogenesis

Farshid S. Garmaroudi et al.

FUTURE MICROBIOLOGY (2015)

Add to Collection

Article Chemistry, Medicinal

Novel N-Benzenesulfonyl Sophocarpinol Derivatives as Coxsackie B Virus Inhibitors

Sheng Tang et al.

ACS MEDICINAL CHEMISTRY LETTERS (2015)

Add to Collection

Article Microbiology

Recombinant Human Coxsackievirus B3 from Children with Acute Myocarditis in China

Zhiqiang Wu et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2013)

Add to Collection

Article Chemistry, Medicinal

Efficient synthesis and anti-enteroviral activity of 9-arylpurines

Leire Aguado et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Add to Collection

Article Immunology

Increased Activity of Coxsackievirus B1 Strains Associated with Severe Disease among Young Infants in the United States, 2007-2008

Mary E. Wikswo et al.

CLINICAL INFECTIOUS DISEASES (2009)

Add to Collection

Article Virology

Interaction of decay-accelerating factor with coxsackievirus B3

Susan Hafenstein et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Infectious Diseases

Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril:: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment

M Schmidtke et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.